Phathom Pharmaceuticals Quote - PHAT

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

5.77

Bid

5.67

Ask

5.73

Volume

723,073

5.53 Day's Range 5.755

5.21 52 Week Range 19.675

Market Cap

394.537M

Previous Close

5.54

Open

5.59

Last Trade

5.67

Last Trade Time

Financial Volume

US$ 4,058,239

VWAP

5.6125

Average Volume (3m)

983,304

Shares Outstanding

68,377,379

Dividend Yield

PE Ratio

-1.93

Earnings Per Share (EPS)

-2.95

Revenue

682k

Net Profit

-201.59M

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that ... Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.phathompharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Phathom Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHAT. The last closing price for Phathom Pharmaceuticals was US$5.54. Over the last year, Phathom Pharmaceuticals shares have traded in a share price range of US$ 5.21 to US$ 19.675.

Phathom Pharmaceuticals currently has 68,377,379 shares outstanding. The market capitalization of Phathom Pharmaceuticals is US$378.81 million. Phathom Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.93.

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

FLORHAM PARK, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

Citizen Petition seeks correction of expiration date for New Chemical Entity (NCE) exclusivity on VOQUEZNA...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.285	-4.7068538398	6.055	6.21	5.495	953239	5.71464315	CS
4	-1.38	-19.3006993007	7.15	7.25	5.21	1027599	5.95626213	CS
12	-3.13	-35.1685393258	8.9	9.79	5.21	983304	7.10813742	CS
26	-7.12	-55.236617533	12.89	19.675	5.21	1162879	11.82648046	CS
52	-4.16	-41.8932527694	9.93	19.675	5.21	938153	11.36910779	CS
156	-12.28	-68.0332409972	18.05	19.675	5.21	551341	10.66925241	CS
260	-37.24	-86.584515229	43.01	64.54	5.21	369677	13.18052055	CS

PHAT - Frequently Asked Questions (FAQ)

What is the current Phathom Pharmaceuticals share price?

The current share price of Phathom Pharmaceuticals is US$ 5.77

How many Phathom Pharmaceuticals shares are in issue?

Phathom Pharmaceuticals has 68,377,379 shares in issue

What is the market cap of Phathom Pharmaceuticals?

The market capitalisation of Phathom Pharmaceuticals is USD 378.81M

What is the 1 year trading range for Phathom Pharmaceuticals share price?

Phathom Pharmaceuticals has traded in the range of US$ 5.21 to US$ 19.675 during the past year

What is the PE ratio of Phathom Pharmaceuticals?

The price to earnings ratio of Phathom Pharmaceuticals is -1.93

What is the cash to sales ratio of Phathom Pharmaceuticals?

The cash to sales ratio of Phathom Pharmaceuticals is 569

What is the reporting currency for Phathom Pharmaceuticals?

Phathom Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Phathom Pharmaceuticals?

The latest annual turnover of Phathom Pharmaceuticals is USD 682k

What is the latest annual profit for Phathom Pharmaceuticals?

The latest annual profit of Phathom Pharmaceuticals is USD -201.59M

What is the registered address of Phathom Pharmaceuticals?

The registered address for Phathom Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Phathom Pharmaceuticals website address?

The website address for Phathom Pharmaceuticals is www.phathompharma.com

Which industry sector does Phathom Pharmaceuticals operate in?

Phathom Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLGOMicroAlgo Inc	US$ 6.3767 (454.50%)	531.54M
BOXLBoxlight Corporation	US$ 3.1099 (51.70%)	1.84M
GDEVGDEV Inc	US$ 20.90 (46.56%)	264.44k
IVVDInvivyd Inc	US$ 1.7501 (44.64%)	37.75M
UPCUniverse Pharmaceuticals Inc	US$ 0.2003 (40.56%)	420.21M
DOYUDouYu International Holdings Ltd	US$ 7.19 (-55.31%)	1.28M
MNDRMobile health Network Solutions	US$ 0.5048 (-46.29%)	18.61M
BLUEbluebird bio Inc	US$ 4.09 (-41.90%)	5.44M
FLDFold Holdings Inc	US$ 6.95 (-37.39%)	488.54k
GCLGCL Global Holdings Ltd	US$ 3.83 (-31.48%)	635.26k
MLGOMicroAlgo Inc	US$ 6.3767 (454.50%)	531.54M
UPCUniverse Pharmaceuticals Inc	US$ 0.2003 (40.56%)	420.21M
ADTXAditxt Inc	US$ 0.0922 (-22.39%)	278.25M
NVDANVIDIA Corporation	US$ 134.43 (-4.05%)	228.14M
HOLOMicroCloud Hologram Inc	US$ 1.565 (31.51%)	190.81M